Navigation Links
Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform
Date:9/17/2013

Basel, Switzerland (PRWEB) September 17, 2013

Genedata, a leading provider of advanced software solutions for industrial, agricultural, drug discovery, and life science research, today announced that Evonik is extending its collaboration with Genedata. Building on its long-standing partnership with Genedata, Evonik is using the Genedata fully integrated offering that includes Genedata Selector™ for the management and analysis of strain information, scientific data analysis consulting provided by Genedata bioinformatics experts, and specialized IT services. The integrated solution from Genedata will help Evonik advance its industry diversification projects and strengthen the return on its strategic biotechnology investments.

“New, data-intensive and omics-based technologies are catalysts for innovation in the health and food industries,” noted Dr. Ralf Kelle, vice president of R&D Bioproducts for the Evonik Health and Nutrition business unit. “Genedata – with its domain expertise in data analysis and management – helps us get maximum value from our data. More importantly, our relationship with Genedata allows us to benefit from their innovative solutions, which contribute to the success of our resource-efficient and sustainable biotechnology research.”

Beyond Software – Scientific Data Analysis Consulting & Specialized IT Services
Evonik has successfully used Genedata Selector to manage, visualize, and analyze complete genomes of production strain collections with a focus on mutation analysis and deciphering complex genotype-phenotype relationships. Genedata Selector accelerates difficult strain optimization projects for the production of bio-based chemicals, nutritional proteins, food and feed additives, and cosmetics ingredients.

Now, in addition to Genedata Selector enterprise software, Evonik will also use Genedata scientific data analysis consulting services. Based on in-depth and extensive experience in the industrial biotechnology field, these value-added services help to eliminate resource bottlenecks, provide cost-effective support for strategically important projects, and deliver valuable results quickly and efficiently.

Addressing the complete life cycle of R&D projects – from early-stage feasibility studies to late-stage product development – Genedata scientific data analysis consulting delivers:

  • proprietary genome annotations, including gene calling and functional annotations up to the pathway level (for prokaryotes as well as eukaryotes);
  • production strain comparisons, including interpretations of biological effects of variants (e.g. on enzyme activities);
  • cellular signaling network reconstructions for proprietary strains, based on expression and regulatory sequence data;
  • biomarkers, based on omics, NGS, pathway, and functional annotation data; and
  • statistical expression analysis reports (e.g. of microarray or RNAseq data).

In the enterprise R&D environment, Genedata specialized IT services ensure server availability and infrastructure stability for high-performance server infrastructures. These services, which empower researchers to focus more on scientific discovery, include:

  • hosting and remote server maintenance;
  • software and database integration services; and
  • data migration and integration services, including public domain genome release monitoring.

“We are proud of our long-standing and successful partnership with Evonik, a world leader in specialty chemicals,” noted Dr. Othmar Pfannes, CEO of Genedata. “Their adoption of the Genedata Selector application suite, coupled with our scientific consulting and professional IT services, serves as an industry model for other customers in industrial biotechnology research who want to leverage the full advantage of our bioinformatics expertise to achieve their business objectives.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11088626.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
2. Genedata Screener Extends Support for High-Throughput Thermofluor Assays
3. Genedata at ESACT Announces Expansion Into Biopharma Process Development
4. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
5. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
6. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
7. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
10. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
11. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2019)... , ... July 18, 2019 , ... ... announced their investment to enlarge their current piezo motion facilities in Lederhose, Germany, ... 3 floors for multilayer piezo ceramic assembly production in addition to general office ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response ... Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel ...
(Date:7/2/2019)... ... 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , ... The film focuses on regenerative veterinary medicine as a means of improving the ... included in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, ...
(Date:6/12/2019)... ... June 12, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is ... signed. The agreement will grant exclusive rights for Zillion to represent LDA in ...
Breaking Biology Technology:
(Date:7/26/2019)... ... 25, 2019 , ... Lemnis Technologies, the technology company behind ... a new generation eye tracker with hassle-free calibration. The headsets will be demonstrated ... - August 1). SIGGRAPH attendees will be able to try Verifocal™ headsets in ...
(Date:7/23/2019)... ... July 22, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... of osteoarthritis in the knee. , This is the first of several ...
(Date:7/19/2019)... POWAY, Calif. (PRWEB) , ... July 18, 2019 , ... ... with clinical, regulatory and manufacturing experience. As a result of a two-year ... to commercialize the Calidi oncolytic virus platform in veterinary medicine. VetStem should be ...
Breaking Biology News(10 mins):